跳至主要内容
临床试验/IRCT20150107020592N23
IRCT20150107020592N23招募中2 期

Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • age of patients ranged between 8 to 16 years2.COVID-19 POSITIVE3. interleukin above 6 4.Patients hospitalized in the intensive care unit5.Increased respiration rate (be30 beats / min), difficulty breathing, cyanosis of the lips6.Oxygen saturation percentage =93%
  • .COVID-19 positive
  • interleukin above 6
  • Patients hospitalized in the intensive care unit
  • Increased respiration rate (be30 beats / min), difficulty breathing, cyanosis of the lips
  • Oxygen saturation percentage =93%,PaO2 / FiO2 =300 mmHg
  • Patients with covid-19 disease receiving antiretroviral therapy such as Favipiravir ,remdesivir, and kaletra have experienced an increase in interleukin and a cytokine storm during treatment.

排除标准

  • Patients treated with other interleukin-lowering methods, such as Actemra

研究者

相似试验